htgc.comHercules Capital | Venture Debt - Business Capital - Funding

 Life Sciences Technology SaaS Finance Sustainable + Renewable Special Situations Select Page Life Sciences Technology SaaS Finance Sustainable + Renewable Special Situations About Meet our team Investor Relations Portfolio Careers Giving Back Press Releases Contact Us × Empowering Innovators Meet our Team Hercules Capital is the largest business development company focused on venture lending, and the lender of choice for innovative entrepreneurs and their venture capital partners. in commitments IPO and M&A exits companies funded assets under management co-investments with VC & PE firms new debt & equity commitments in commitments assets under management IPO and M&A exits co-investments with VC & PE firms companies funded new debt & equity commitments (a) Since inception through December 31, 2020 (b) Q4 2020 INDUSTRIES WE SERVE Technology Life Sciences Sustainable + Renewable Special Situations The Hercules Team View All Hercules has been a great partner for Box since 2008. They were very supportive during the financial crisis and grew through multiple transactions as our business started to scale. The Hercules team is flexible, creative and easy to work with. I would highly recommend them for any growth company looking for capital. Dylan Smith (CFO, Box) Featured Portfolio Companies Life Sciences Technology SaaS Finance Sustainable + Renewable Special Situations Paratek Pharmaceuticals Paratek Pharmaceuticals, Inc. is a privately held biopharmaceutical company engaged in the discovery and commercialization of new therapeutics that treat life threatening infectious and other serious diseases. www.paratekpharm.com Celator Pharmaceuticals Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. Celator's proprietary technology platform, CombiPlex, enables the rational design and rapid evaluation of optimized combinations, incorporating traditional chemotherapies as well as molecularly targeted agents to deliver enhanced anti-cancer activity. Acquired by Jazz Pharmaceuticals in 2016. www.celatorpharma.com ChemoCentryx ChemoCentryx is a focused pharmaceutical company creating first-in-class, orally available medicines for autoimmune diseases, inflammatory disorders and oncology. By leveraging their pioneering expertise in the field of chemokine research, ChemoCentryx has generated a broad portfolio of medicines targeting the chemokine system, with six product candidates currently in pre-clinical and clinical stages of development. www.chemocentryx.com Thumbtack Thumbtack provides a marketplace and review site for local services. All service providers create an online profile, then manage an online appointment calendar, accept online payments, and begin local marketing campaigns. Thumbtack also lets would-be employers vet the identity of the service providers before providing any financial information or booking an appointment. www.thumbtack.com BitSight BitSight transforms how organizations manage cyber risk. The BitSight Security Ratings Platform applies sophisticated algorithms, producing daily security ratings that range from 250 to 900, to help organizations manage their own security performance; mitigate third party risk; underwrite cyber insurance policies; conduct financial diligence; and assess aggregate risk. www.bitsight.com AppDirect AppDirect eliminates the risk of delivering white label tech support to end users with complete solution packages that include call center resources, software, and technology and operational expertise. www.appdirect.com Proterra Proterra is a leader in the design and manufacture of zero-emission electric buses that reduce fleet operating costs and eliminate dependency on fossil-fuels. www.proterra.com TPI Composites, Inc. TPI Composites is a global provider of wind turbine blades and other advanced structural composites products, with more than 2,000 employees who are also expert innovators in the transportation and military vehicle markets. www.tpicomposites.com Rive Technology Rive is a developer of innovative materials-based solutions for catalytic and separations processes in the petroleum refining, chemicals, and biofuels industries. Through its Molecular Highway technology, an innovative materials science platform, Rive enables higher performing catalysts and adsorbents. Rive is commercializing its Molecular Highway technology for the petroleum refining industry, specifically fluid catalytic cracking, with W.R. Grace (NYSE: GRA) through jointly developed FCC catalysts. FCC catalysts powered by Molecular Highway technology allow refiners to profit by increasing production of high-quality fuels and by processing heavier crudes. www.rivetechnology.com ReachLocal ReachLocal, Inc. (NASDAQ:RLOC) helps local businesses grow and operate their business better with leading technology and expert service for our clients' lead generation and conversion. www.reachlocal.com Mattersight Mattersight helps brands have better chemistry with their customers. Using a suite of innovative personality-based products, Mattersight can analyze and predict customer behavior based on the language exchanged during service and sales interactions. This insight can then facilitate real-time connections between customers and the agents best capable of handling their needs. Mattersight's patented stack of SaaS products has influenced hundreds of millions of shorter, more satisfying customer interactions. Organizations across the Financial Services, Healthcare, Technology, and Telco industries rely on Mattersight to drive customer retention, employee engagement, and operating efficiency. www.mattersight.com Vela Trading Vela Trading Technologies (“Vela”) is a leading provider of market data software, managed services, and content to global financial services clients, connecting banks, hedge funds, and other buy and sell-side firms to the global markets for trading across many asset classes. Vela software processes pricing, trading, and other data from exchanges (and other sources), cleans and normalizes that data, and distributes it for a variety of trading and order execution applications. www.velatradingtech.com View All Life Sciences Technology Sustainable + Renewable Special Situations Hercules’ understanding and decades of experience working with companies in the life sciences sector meant they were able to recognize the elements – an experienced management team, a solid product and a well-managed balance sheet – that make up a company positioned to realize its full potential. Read more By turning to Hercules, a specialty finance company that focused on venture debt in the technology space, Druva was able to access more capital than a traditional bank could provide and avoid the dilution that would be caused by raising additional equity. Read more Plug Power had been experiencing tremendous growth and needed to obtain non-dilutive, growth capital. This would mean finding a financial partner that could understand its sophisticated financing structure which included a number of instruments like sale/leaseback project financing. Read more The Hercules’ Special Situations underwriting team recognized that despite setbacks, ReachLocal’s fundamentals remained strong, and the company was led by a very talented management team. In April 2015, ReachLocal closed on a $25 million long-term loan facility with Hercules Capital to meet working capital needs. Read more Work with us 400 Hamilton Ave. Suite 310, Palo Alto, CA 94301 650.289.3060 Info@htgc.com Follow us on Life Sciences Technology SaaS Finance Sustainable + Renewable Special Situations About Meet Our Team Investor Relations Portfolio Careers Giving Back Press Releases Contact Us Follow us on © Copyright Hercules Capital 2021 Terms and Conditions | Privacy Policy | California Notice at Collection and Privacy Policy Facebook Twitter Google © 2021 Hercules Capital...